The acquisition enhances DSM-Firmenich’s presence in several markets, including early-life nutrition, medical nutrition, and the microbiome market for pet health and animal feed.
DSM-Firmenich (Kaiseraugst, Switzerland; Heerlen, Netherlands) has completed the acquisition of Adare Biome (Lawrenceville, NJ), a developer of postbiotic ingredients, for €275 million. The acquisition enhances DSM-Firmenich’s presence in several markets, including early-life nutrition, medical nutrition, and the microbiome market for pet health and animal feed.
Specifically, DSM-Firmenich notes that through its B2C group i-Health, the company plans to expand the reach of Adare Biome’s Lactéol postbiotic supplement for relieving stomach upset.
“The Adare Biome teams will greatly help in driving our ‘Health from the Gut’ strategy and enable us to accelerate the creation of next-generation biotics to support the health of people and animals,” stated Philip Eykerman, president of Health, Nutrition, & Care at DSM-Firmenich, in a press release.
The company calls postbiotics “the next wave of opportunity in the gut health market,” stating that postbiotic ingredients offer longer shelf-life and broader application possibilities compared to probiotics.
OmniActive partners with CRN to raise awareness about macular carotenoids for prenatal health
May 6th 2024OmniActive Health Technologies has announced a partnership with the Council for Responsible Nutrition to educate and raise awareness about the role of lutein and zeaxanthin in supporting maternal and fetal health during pregnancy among obstetricians, gynecologists, and other maternal healthcare practitioners.
What's next for NPA and CRN in their complaints against New York state?
May 2nd 2024The latest updates in the efforts of the Natural Products Association and the Council for Responsible Nutrition to sue New York state for its law banning the sale of weight management and muscle building supplements to minors.